Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 13/20 | 1.00 |
| ▸ | S100A4 | P26447 | 8/20 | 1.00 |
| ▸ | CDC25A | P30304 | 7/20 | 1.00 |
| ▸ | MAP2K7 | O14733 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | APAF1 | O14727 | 3/20 | 1.00 |
| ▸ | TDP2 | O95551 | 3/20 | 1.00 |
| ▸ | CDC25C | P30307 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | PLA2G1B | P04054 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | THRB | P10828 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | GALK1 | P51570 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17323863 | 0.91 | CDC25B (0.83) | CDC25BS100A4CDC25AMAP2K7MEN1 | |
| SCHEMBL16138413 | 0.89 | CDC25B (0.80) | CDC25BS100A4CDC25AMAP2K7MEN1 | |
| SCHEMBL2599202 | 0.89 | CDC25B (1.00) | CDC25BS100A4CDC25AMAP2K7MEN1 | |
| SCHEMBL15630311 | 0.87 | CDC25A (0.77) | CDC25BS100A4CDC25AMAP2K7MEN1 | |
| SCHEMBL15679343 | 0.83 | CDC25B (0.70) | CDC25BS100A4CDC25AMAP2K7MEN1 | |
| SCHEMBL23567913 | 0.81 | CDC25B (0.74) | CDC25BS100A4CDC25AMAP2K7MEN1 | |
| SCHEMBL20398309 | 0.78 | CDC25B (0.64) | CDC25BS100A4CDC25AMAP2K7MEN1 | |
| SCHEMBL2599403 | 0.76 | S100A4 (1.00) | CDC25BS100A4CDC25AMAP2K7MEN1 | |
| SCHEMBL4629512 | 0.76 | S100A4 (0.76) | CDC25BS100A4CDC25AMAP2K7MEN1 | |
| SCHEMBL1197875 | 0.76 | NPC1 (0.61) | CDC25BS100A4CDC25AMAP2K7MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4057813-A1 | COMPOSITIONS AND METHODS FOR TREATING HUANGLONGBING DISEASE IN CITRUS | New Life Crop Sciences LLC (US) | 2022-09-21 | — | — | EP | claimed |
| CN-114980736-A | Compositions and methods for treating citrus greening disease | 新生命作物科学有限责任公司 | 2022-08-30 | — | — | CN | claimed |
| US-20210144998-A1 | COMPOSITIONS AND METHODS FOR TREATING HUANGLONGBING DISEASE IN CITRUS | NEW LIFE CROP SCIENCES LLC | 2021-05-20 | — | — | US | claimed |
| US-10543282-B2 | Targeted peptide conjugates | MARKER GENE TECHNOLOGIES, INC (US) | 2020-01-28 | — | — | US | claimed |
| US-20180207287-A1 | TARGETED PEPTIDE CONJUGATES | MARKER GENE TECHNOLOGIES, INC. | 2018-07-26 | — | — | US | claimed |
| US-9018176-B2 | Inducers of hematopoiesis and fetal globin production for treatment of cytopenias and hemoglobin disorders | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-04-28 | — | — | US | claimed |
| US-20130090355-A1 | CHEMICAL AGENTS FOR THE PREVENTION OF INHIBITION OR TUMOR METASTASIS | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2013-04-11 | — | — | US | claimed |
| WO-2011146101-A1 | CHEMICAL AGENTS FOR THE PREVENTION OR INHIBITION OF TUMOR METASTASIS | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2011-11-24 | — | — | WO | claimed |
| US-20250381202-A1 | PRODRUG KIT FOR MULTI-PRONGED CHEMOTHERAPY | ZOUNEK ALEX (DE) | 2025-12-18 | — | — | US | disclosed |
| US-20250027041-A1 | COMPOSITION FOR INDUCING TRANSDIFFERENTIATION AND STEM CELLS TREATED THEREWITH | YJ Cerapeutics Inc. (KR) | 2025-01-23 | — | — | US | disclosed |
| WO-2024242637-A1 | A NOVEL SELF-AMPLIFYING RNA | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2024-11-28 | — | — | WO | disclosed |
| EP-4455273-A1 | COMPOSITION FOR INDUCING TRANSDIFFERENTIATION AND STEM CELLS TREATED THEREWITH | YJ Cerapeutics Inc. (KR) | 2024-10-30 | — | — | EP | disclosed |
| CN-118284688-A | Composition for direct transdifferentiation induction and stem cell treated with the same | 外治世拉普提斯株式会社 | 2024-07-02 | — | — | CN | disclosed |
| WO-2023090971-A1 | COMPOSITION FOR INDUCING TRANSDIFFERENTIATION AND STEM CELLS TREATED THEREWITH | 주식회사 와이제이세라퓨틱스 | 2023-05-25 | — | — | WO | disclosed |
| CN-101415420-A | Combination of therapeutic agents for the treatment of cancer | NOVARTIS AG (CH) | 2009-04-22 | — | — | CN | disclosed |
| US-20090012107-A1 | Antiviral Compounds and Methods of Using Thereof | U.S. ARMY MEDICAL RESEARCH AND MATERIEL COMMAND | 2009-01-08 | — | — | US | disclosed |
| US-20070258913-A1 | Composition for Inhibiting or Preventing the Formation of a Biofilm | OYSTERSHELL NV (BE) | 2007-11-08 | — | — | US | disclosed |
| EP-1796656-A2 | COMPOSITION FOR INHIBITING OR PREVENTING THE FORMATION OF A BIOFILM | Oystershell NV (BE) | 2007-06-20 | — | — | EP | disclosed |
| US-20060223092-A1 | Assays, methods and kits for detecting small nuclear ribonucleoprotein particle assembly and survival of motor neurons activity | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2006-10-05 | — | — | US | disclosed |
| WO-2006029893-A2 | COMPOSITION FOR INHIBITING OR PREVENTING THE FORMATION OF A BIOFILM | OYSTERSHELL NV (BE) | 2006-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250381202-A1 | PRODRUG KIT FOR MULTI-PRONGED CHEMOTHERAPY | KIT, CTSL, PAICS | CDC25B 69/4885S100A4 3477/4885CDC25A 91/4885 |
| US-20090012107-A1 | Antiviral Compounds and Methods of Using Thereof | ZC3HAV1, MAVS, ZC3HAV1L | CDC25B 3675/4885S100A4 1628/4885CDC25A 3086/4885 |
| US-20250027041-A1 | COMPOSITION FOR INDUCING TRANSDIFFERENTIATION AND STEM CELLS TREATED THEREWITH | CTBP2, TARDBP, NES | CDC25B 3641/4885S100A4 632/4885CDC25A 3433/4885 |
| US-20070258913-A1 | Composition for Inhibiting or Preventing the Formation of a Biofilm | NQO2, NFKBIA, CROCC | CDC25B 2143/4885S100A4 3710/4885CDC25A 1650/4885 |
| US-20130090355-A1 | CHEMICAL AGENTS FOR THE PREVENTION OF INHIBITION OR TUMOR METASTASIS | S100A4, S100A6, S100A10 | CDC25B 211/4885S100A4 1/4885CDC25A 248/4885 |
| US-20180207287-A1 | TARGETED PEPTIDE CONJUGATES | VCP, NLN, GOLT1B | CDC25B 3840/4885S100A4 4627/4885CDC25A 3958/4885 |
| US-10543282-B2 | Targeted peptide conjugates | VCP, NLN, GOLT1B | CDC25B 3840/4885S100A4 4627/4885CDC25A 3958/4885 |
| US-20210144998-A1 | COMPOSITIONS AND METHODS FOR TREATING HUANGLONGBING DISEASE IN CITRUS | PNPO, G6PD, AGXT | CDC25B 1481/4885S100A4 2971/4885CDC25A 2017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.